Sangaletti S - Search Results

1

Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.

Mauri G, Jachetti E, Comuzzi B, Dugo M, Arioli I, Miotti S, Sangaletti S, Di Carlo E, Tripodo C, Colombo MP. Mauri G, et al. Among authors: sangaletti s. Oncotarget. 2016 Jan 26;7(4):3905-20. doi: 10.18632/oncotarget.6678. Oncotarget. 2016. PMID: 26700622 Free PMC article.

2

Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases.

Chiodoni C, Stoppacciaro A, Sangaletti S, Gri G, Cappetti B, Koezuka Y, Colombo MP. Chiodoni C, et al. Among authors: sangaletti s. Eur J Immunol. 2001 Oct;31(10):3101-10. doi: 10.1002/1521-4141(2001010)31:10<3101::aid-immu3101>3.0.co;2-8. Eur J Immunol. 2001. PMID: 11592087 Free article.

3

Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo.

Rotta G, Edwards EW, Sangaletti S, Bennett C, Ronzoni S, Colombo MP, Steinman RM, Randolph GJ, Rescigno M. Rotta G, et al. Among authors: sangaletti s. J Exp Med. 2003 Oct 20;198(8):1253-63. doi: 10.1084/jem.20030335. J Exp Med. 2003. PMID: 14568983 Free PMC article.

4

Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.

Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP. Sangaletti S, et al. J Exp Med. 2003 Nov 17;198(10):1475-85. doi: 10.1084/jem.20030202. Epub 2003 Nov 10. J Exp Med. 2003. PMID: 14610043 Free PMC article.

5

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP. Guiducci C, et al. Among authors: sangaletti s. Cancer Res. 2005 Apr 15;65(8):3437-46. doi: 10.1158/0008-5472.CAN-04-4262. Cancer Res. 2005. PMID: 15833879

6

Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice.

Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, Stoppacciaro A, Chiodoni C, Colombo MP. Sangaletti S, et al. J Cell Sci. 2005 Aug 15;118(Pt 16):3685-94. doi: 10.1242/jcs.02474. Epub 2005 Jul 26. J Cell Sci. 2005. PMID: 16046482

7

Triggering CD40 on endothelial cells contributes to tumor growth.

Chiodoni C, Iezzi M, Guiducci C, Sangaletti S, Alessandrini I, Ratti C, Tiboni F, Musiani P, Granger DN, Colombo MP. Chiodoni C, et al. Among authors: sangaletti s. J Exp Med. 2006 Oct 30;203(11):2441-50. doi: 10.1084/jem.20060844. Epub 2006 Oct 16. J Exp Med. 2006. PMID: 17043144 Free PMC article.

8

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.

Melani C, Sangaletti S, Barazzetta FM, Werb Z, Colombo MP. Melani C, et al. Among authors: sangaletti s. Cancer Res. 2007 Dec 1;67(23):11438-46. doi: 10.1158/0008-5472.CAN-07-1882. Cancer Res. 2007. PMID: 18056472 Free PMC article.

9

Matricellular proteins at the crossroad of inflammation and cancer.

Sangaletti S, Colombo MP. Sangaletti S, et al. Cancer Lett. 2008 Aug 28;267(2):245-53. doi: 10.1016/j.canlet.2008.03.027. Epub 2008 May 8. Cancer Lett. 2008. PMID: 18471960 Review.

10

Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.

Sangaletti S, Di Carlo E, Gariboldi S, Miotti S, Cappetti B, Parenza M, Rumio C, Brekken RA, Chiodoni C, Colombo MP. Sangaletti S, et al. Cancer Res. 2008 Nov 1;68(21):9050-9. doi: 10.1158/0008-5472.CAN-08-1327. Cancer Res. 2008. PMID: 18974151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters